These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8738468)

  • 1. A fas antigen receptor mutation allows development of toxic shock syndrome toxin-1-induced lethal shock in V beta 8.2 T-cell receptor transgenic mice.
    Cullen CM; Bonventre PF; Heeg H; Bluethmann H; Mountz JD; Edwards CK
    Pathobiology; 1995; 63(6):293-304. PubMed ID: 8738468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity.
    Bonventre PF; Heeg H; Edwards CK; Cullen CM
    Infect Immun; 1995 Feb; 63(2):509-15. PubMed ID: 7822015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased susceptibility of fas mutant MRL-lpr/lpr mice to staphylococcal enterotoxin B-induced septic shock.
    Mountz JD; Baker TJ; Borcherding DR; Bluethmann H; Zhou T; Edwards CK
    J Immunol; 1995 Nov; 155(10):4829-37. PubMed ID: 7594485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha.
    Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD
    J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
    Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
    J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
    Miethke T; Wahl C; Heeg K; Wagner H
    J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell influence on superantigen-induced arthritis in MRL-lpr/lpr mice.
    Mountz JD; Zhou T; Long RE; Bluethmann H; Koopman WJ; Edwards CK
    Arthritis Rheum; 1994 Jan; 37(1):113-24. PubMed ID: 7907476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells.
    Kum WW; Cameron SB; Hung RW; Kalyan S; Chow AW
    Infect Immun; 2001 Dec; 69(12):7544-9. PubMed ID: 11705931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
    J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective maintenance of T cell tolerance to a superantigen in MRL-lpr/lpr mice.
    Zhou T; Bluethmann H; Zhang J; Edwards CK; Mountz JD
    J Exp Med; 1992 Oct; 176(4):1063-72. PubMed ID: 1402652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superantigen and endotoxin synergize in the induction of lethal shock.
    Blank C; Luz A; Bendigs S; Erdmann A; Wagner H; Heeg K
    Eur J Immunol; 1997 Apr; 27(4):825-33. PubMed ID: 9130631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
    Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
    Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis defects analyzed in TcR transgenic and fas transgenic lpr mice.
    Mountz JD; Zhou T; Bluethmann H; Wu J; Edwards CK
    Int Rev Immunol; 1994; 11(4):321-42. PubMed ID: 7528763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A central role for CD95 (Fas) in T-cell reactivity after injury.
    Kell MR; Shelley O; Mannick JA; Guo Z; Lederer JA
    Surgery; 2000 Aug; 128(2):159-64. PubMed ID: 10922986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal sequence and functional implications of V beta-specific T cell receptor down-regulation and costimulatory molecule expression following in vitro stimulation with the staphylococcal superantigen Toxic shock syndrome toxin-1.
    Kum WW; Hung RW; Cameron SB; Chow AW
    J Infect Dis; 2002 Feb; 185(4):555-60. PubMed ID: 11865410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
    Kuroda K; Yagi J; Imanishi K; Yan XJ; Li XY; Fujimaki W; Kato H; Miyoshi-Akiyama T; Kumazawa Y; Abe H; Uchiyama T
    J Immunol; 1996 Aug; 157(4):1422-31. PubMed ID: 8759722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of peripheral T cell deletion: anergized T cells are Fas resistant but undergo proliferation-associated apoptosis.
    Miethke T; Vabulas R; Bittlingmaier R; Heeg K; Wagner H
    Eur J Immunol; 1996 Jul; 26(7):1459-67. PubMed ID: 8766547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of superantigen-mediated toxic shock: not a simple Th1 cytokine storm.
    Faulkner L; Cooper A; Fantino C; Altmann DM; Sriskandan S
    J Immunol; 2005 Nov; 175(10):6870-7. PubMed ID: 16272345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci.
    Abdelnour A; Bremell T; Holmdahl R; Tarkowski A
    Eur J Immunol; 1994 May; 24(5):1161-6. PubMed ID: 8181526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The toxic shock syndrome toxin-1 induces anergy in human T cells in vivo.
    Mahlknecht U; Herter M; Hoffmann MK; Niethammer D; Dannecker GE
    Hum Immunol; 1996 Jan; 45(1):42-5. PubMed ID: 8655359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.